DJIA 17,084.49 33.74 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo

Celgene (NASDAQ: CELG)

117.38 -0.59 (-0.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $117.38 -0.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $117.62
Previous Close $117.97
Daily Range $115.80 - $118.50
52-Week Range $83.16 - $140.72
Market Cap $92.8B
P/E Ratio 44.69
Dividend (Yield) $0.00 (0.0%)
Volume 5,051,169
Average Daily Volume 6,211,088
Current FY EPS $4.36




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

Biotech's Bloodbath Is Ridiculous; Here's Why

Biotech stocks have been getting pummeled in the last two months. A deeper look at the root cause of this sell-off, though, shows that it's probably unwarranted, making now a great time to buy these stocks on the cheap.

The Hedged Portfolio Method

4 Biotech Stocks Now at Bargain Prices

Celgene Announces New Data for OTEZLA® (Apremilast) Will Be Presented at European Academy of Dermato

Celgene Announces New Data for OTEZLA® (Apremilast) Will Be Presented at European Academy of Dermatology and Venereology Congress

Why We Should Take This Biotech Selloff Seriously

Stock Market News for October 08, 2015

Biogen Caused Biotech Collapse but Might Also Lead Stocks Higher

Concert Pharmaceuticals Announces $8 Million Milestone from Celgene

Stock Market News for October 07, 2015

Cramer -- Take Cisco Over Juniper and Buy Celgene, Too

XLV, ABBV, CELG, ESRX: Large Inflows Detected at ETF

See More CELG News...

CELG's Top Competitors

CELG $117.38 (-0.50%)
Current stock: CELG
AMGN $149.59 (-0.21%)
Current stock: AMGN
GILD $100.65 (-0.16%)
Current stock: GILD
$0.00 (0.00%)
Current stock: